Beam Therapeutics BEAM
NASDAQ BEAM
$24.39 -0.06 (-0.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

Beam Therapeutics (BEAM) Non-Current Deffered Revenue (2020 - 2025)

Updated

Beam Therapeutics (BEAM) reported Non-Current Deffered Revenue of $10.16 million for Q3 2025, down 82.4% from $57.82 million a year earlier and down 50.0% from the prior quarter.

Analysis

Beam Therapeutics (BEAM) Non-Current Deffered Revenue (2020 - 2025) Analysis & Trends

At the end of FY2024, Beam Therapeutics posted Non-Current Deffered Revenue of $33.22 million, down 69.8% from FY2023.

  • Non-Current Deffered Revenue has declined for three consecutive years, though with a four-year compound annual growth rate of 203.0% (FY2020 to FY2024).
  • By year, Non-Current Deffered Revenue came in at $109.89 million in FY2023 (-45.6%), $202.18 million in FY2022 (-22.9%), $262.3 million in FY2021 and $394,000 in FY2020.
  • The Q3 2025 figure ranks as the lowest quarterly Non-Current Deffered Revenue since Q4 2020.
  • Year over year, Non-Current Deffered Revenue has now declined in each of the last 12 quarters, with an average decline of 58.6% over the last eight quarters.
  • The high point for year-over-year Non-Current Deffered Revenue in five years was Q3 2022 (growth of 438.5%); the low point was Q3 2025 (a decline of 82.4%).
  • Per Business Quant data, the three quarters before Q3 2025 came in at $20.32 million (Q2 2025), $49.4 million (Q1 2025) and $33.22 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Beam Therapeutics 2.52 Bn 2.52 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 10.16 Mn
Jun 30, 2025 20.32 Mn
Mar 31, 2025 49.40 Mn
Dec 31, 2024 33.22 Mn
Sep 30, 2024 57.82 Mn
Jun 30, 2024 75.49 Mn
Mar 31, 2024 99.57 Mn
Dec 31, 2023 109.89 Mn
Sep 30, 2023 124.65 Mn
Jun 30, 2023 156.20 Mn
Mar 31, 2023 171.71 Mn
Dec 31, 2022 202.18 Mn
Sep 30, 2022 198.29 Mn
Jun 30, 2022 208.82 Mn
Mar 31, 2022 225.09 Mn
Dec 31, 2021 262.30 Mn
Sep 30, 2021 36.82 Mn
Jun 30, 2021 40.38 Mn
Dec 31, 2020 394,000.00
API Access

Beam Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BEAM&period=max&api_key=YOUR_API_KEY